Signal2026-07-04
PubMed

A synergistic nanoplatform integrating phototherapy-triggered immunogenic cell death and PKM2-targeted gene therapy for durable tumor control.

Part of

Cancer Nanomedicine And Liquid Biopsy

Open primary sourceSee the whole picture